Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2001-02-09
2004-12-14
Russel, Jeffrey Edwin (Department: 1654)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C424S486000, C514S021800, C606S214000
Reexamination Certificate
active
06830756
ABSTRACT:
FIELD OF THE INVENTION
The invention generally relates to the composition of biocompatible materials and their application to body tissue to affect desired therapeutic results.
BACKGROUND OF THE INVENTION
There are many therapeutic indications today that pose problems in terms of technique, cost efficiency, or efficacy, or combinations thereof.
For example, following an interventional procedure, such as angioplasty or stent placement, a 5 Fr to 8 Fr arteriotomy remains. Typically, the bleeding from the arteriotomy is controlled through pressure applied by hand, by sandbag, or by C-clamp for at least 30 minutes. While pressure will ultimately achieve hemostasis, the excessive use and cost of health care personnel is incongruent with managed care goals.
Various alternative methods for sealing a vascular puncture site have been tried. For example, collagen plugs have been used to occlude the puncture orifice. The collagen plugs are intended to activate platelets and accelerate the natural healing process. Holding the collagen seals in place using an anchor located inside the artery has also been tried. Still, patient immobilization is required until clot formation stabilizes the site. Other problems, such as distal embolization of the collagen, rebleeding, and the need for external pressure to achieve hemostatis, also persist.
As another example, devices that surgically suture the puncture site percutaneously have also been used. The devices require the practice of fine surgical skills to place needles at a precise distance from the edges of the puncture orifice and to form an array of suture knots, which are tightened and pushed from the skin surface to the artery wall with a knot pusher, resulting in puncture edge apposition.
There remains a need for fast and straightforward mechanical and chemical systems and methods to close vascular puncture sites and to accelerate the patient's return to ambulatory status without pain and prolonged immobilization.
There also remains a demand for biomaterials that improve the technique, cost efficiency, and efficacy of these and other therapeutic indications.
SUMMARY OF THE INVENTION
The invention provides systems, methods, and compositions for achieving closure of vascular puncture sites. The systems and methods form a vascular closure composition by mixing together a first component, a second component, and a buffer material. The first component includes electrophilic polymer material having a functionality of at least three. The second component includes a nucleophilic material that, when mixed with the first component within a reaction pH range of between 7 to 9, cross-links with the first component to form a non-liquid, three-dimensional barrier. The buffer material has a pH within the reaction pH range. The systems and methods apply the composition to seal a vascular puncture site.
In a preferred embodiment, the first component comprises poly(ethylene glycol) having a molecular weight between 9,000 and 12,000. In a most preferred embodiment, the poly(ethylene glycol) has a molecular weight of 10,500±1500. In these preferred embodiments, the second component comprises human serum albumin at a concentration of about 25% or less, and the buffer material includes tris-hydroxymethylaminomethane. The buffer material can also include sodium carbonate anhydrous. In a preferred embodiment, the second component, when mixed with the buffer material, and prior to mixing with the first component, has a pH of between 8.3 and 8.5.
Compositions that embody features of the invention are successful in sealing femoral puncture sites in less than 40 seconds.
Features and advantages of the inventions are set forth in the following Description and Drawings, as well as in the appended claims.
REFERENCES:
patent: 4101380 (1978-07-01), Rubinstein et al.
patent: 4161948 (1979-07-01), Bichon
patent: 4464468 (1984-08-01), Avrameas et al.
patent: 4839345 (1989-06-01), Doi et al.
patent: 5051406 (1991-09-01), Satoh
patent: 5129882 (1992-07-01), Weldon et al.
patent: 5207670 (1993-05-01), Sinofsky
patent: 5252714 (1993-10-01), Harris et al.
patent: 5318524 (1994-06-01), Morse et al.
patent: 5383896 (1995-01-01), Gershony et al.
patent: 5403278 (1995-04-01), Ernst et al.
patent: 5410016 (1995-04-01), Hubbell et al.
patent: 5419765 (1995-05-01), Weldon et al.
patent: 5514379 (1996-05-01), Weissleder et al.
patent: 5520885 (1996-05-01), Coelho et al.
patent: 5529577 (1996-06-01), Hammerslag
patent: 5567435 (1996-10-01), Hubbell et al.
patent: 5583114 (1996-12-01), Barrows et al.
patent: 5601602 (1997-02-01), Fowler
patent: 5626601 (1997-05-01), Gershony et al.
patent: 5626863 (1997-05-01), Hubbell et al.
patent: 5653730 (1997-08-01), Hammerslag
patent: 5672662 (1997-09-01), Harris et al.
patent: 5676689 (1997-10-01), Kensey et al.
patent: 5725498 (1998-03-01), Janzen et al.
patent: 5733563 (1998-03-01), Fortier
patent: 5739208 (1998-04-01), Harris
patent: 5759194 (1998-06-01), Hammerslag
patent: 5782860 (1998-07-01), Epstein et al.
patent: 5791352 (1998-08-01), Reich et al.
patent: 5824015 (1998-10-01), Sawyer
patent: 5843124 (1998-12-01), Hammerslag
patent: 5844016 (1998-12-01), Sawhney et al.
patent: 5858746 (1999-01-01), Hubbell et al.
patent: 5874500 (1999-02-01), Rhee et al.
patent: 5900245 (1999-05-01), Sawhney et al.
patent: 5900461 (1999-05-01), Harris
patent: 5922009 (1999-07-01), Epstein et al.
patent: 5932462 (1999-08-01), Harris et al.
patent: 5935147 (1999-08-01), Kensey et al.
patent: 5936035 (1999-08-01), Rhee et al.
patent: 5942209 (1999-08-01), Leavitt et al.
patent: 5951583 (1999-09-01), Jensen et al.
patent: 5951589 (1999-09-01), Epstein et al.
patent: 5986043 (1999-11-01), Hubbell et al.
patent: 5990237 (1999-11-01), Bentley et al.
patent: 6007613 (1999-12-01), Izoret
patent: 6022361 (2000-02-01), Epstein et al.
patent: 6051248 (2000-04-01), Sawhney et al.
patent: 6060582 (2000-05-01), Hubbell et al.
patent: 6083524 (2000-07-01), Sawhney et al.
patent: 6152943 (2000-11-01), Sawhney
patent: 6162241 (2000-12-01), Coury et al.
patent: 6165201 (2000-12-01), Sawhney et al.
patent: 6177095 (2001-01-01), Sawhney et al.
patent: 6179862 (2001-01-01), Sawhney
patent: 6302898 (2001-10-01), Edwards et al.
patent: WO 96/11671 (1996-04-01), None
patent: WO 97/22371 (1997-06-01), None
patent: WO 99/07417 (1999-02-01), None
patent: WO 99/14259 (1999-03-01), None
patent: WO 99/45964 (1999-09-01), None
patent: WO 00/09087 (2000-02-01), None
patent: WO 00/09199 (2000-02-01), None
patent: WO 00/33764 (2000-06-01), None
Transactions Society for Biomaterials: Proteolytically Degradable Hydrogels; West et al (1997).
NeoMend, Inc.
Russel Jeffrey Edwin
Ryan Kromholz & Manion S.C.
LandOfFree
Systems, methods, and compositions for achieving closure of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Systems, methods, and compositions for achieving closure of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Systems, methods, and compositions for achieving closure of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3323666